Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Industry: Biotechnology

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Current Quote*
Last: $9.075
Change: 1.000
Book: $8.506
Volume: 111,801

As Of: 07/10 16:13 ET
*Quotes delayed by 20min.

Graphs for FENC


3 Month Graph


6 Month Graph


1 Year Graph